Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

144 trials

NCT06909799
Recruiting
A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease
Not applicable · 1 site
Registry update: 30 Apr 2025
NCT07901387
Recruiting
Biomarker Analysis for Diagnosing and Treatment Monitoring in Extrapulmonary Tuberculosis Patients in Nairobi, Kenya
Not applicable · Kenya · 2 sites
Registry update: 28 Oct 2026
NCT06439810
Recruiting
Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA
Not applicable · Hong Kong · 1 site
Registry update: 31 Mar 2026
NCT06796647
Recruiting
ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients
Not applicable · China, Hong Kong · 2 sites
Registry update: 10 Sept 2025
NCT06916962
Recruiting
Examining Psycho-Socioeconomic Linkages in TB Care: The UPLIFT Trial
Not applicable · Vietnam · 12 sites
Registry update: 8 Apr 2025
NCT06748937
Recruiting
A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide
Phase 2 · South Africa · 1 site
Registry update: 7 Mar 2025
NCT06946784
Recruiting
LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea
Not applicable · South Korea · 1 site
Registry update: 27 Apr 2025
2024-519983-42-00
Recruiting
Rifampicin at High Dose for Difficult-to-Treat Tuberculosis (RIAlta) study
Phase 2 · Spain, Netherlands · 2 sites
Registry update: 4 Feb 2025
NCT06253715
Recruiting
Shortened Regimen for Drug-susceptible TB in Children
Phase 3 · Indonesia, India, Mozambique, Uganda, South Africa, Zambia, Zimbabwe · 9 sites
Registry update: 24 Jul 2026
NCT06670755
Recruiting
ID93/GLA-SE Vaccination + BCG Challenge
Not applicable · United Kingdom · 1 site
Registry update: 22 Oct 2026
NCT06477185
Recruiting
Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline
Phase 2 · Uganda · 2 sites
Registry update: 17 Apr 2025
NCT06281834
Recruiting
Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention
Phase 1 · Nigeria · 1 site
Registry update: 30 Jul 2026
NCT07155954
Recruiting
Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes
Not applicable · China · 1 site
Registry update: 4 Sept 2025
2024-518772-32-00
Recruiting
A randomised, prospective phase II study of pharmacokinetics and safety aspects of higher doses of rifampicin and pyrazinamide in a shortened treatment of mild-to-moderate tuberculosis compared with standard of care
Phase 2 · Sweden · 2 sites
Registry update: 18 Oct 2024
2024-516088-10-00
Recruiting
Phase II study on the safety and efficacy of cysteamine in association with standard tuberculosis therapy for the treatment of patients with pulmonary tuberculosis: a new therapy for tuberculosis directed at the host.
Phase 2 · Italy · 1 site
Registry update: 17 Jul 2025
NCT06352970
Recruiting
Effects of Tuberculosis Infection on Development and Function of the Placenta
Not applicable · Ethiopia · 1 site
Registry update: 3 Sept 2026
NCT06815588
Recruiting
Improving the Outcomes of Children With Tuberculosis Through Innovative Diagnostics and Treatment Monitoring
Not applicable · Romania · 1 site
Registry update: 7 Feb 2025
NCT06526689
Recruiting
Lung Innate Immunity and Microbiome After Tuberculosis Exposure
Not applicable · United Kingdom · 3 sites
Registry update: 22 Jan 2025
NCT05553236
Recruiting
Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis
Not applicable · South Africa · 1 site
Registry update: 26 Jan 2026
NCT06485895
Recruiting
Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis
Not applicable · France · 1 site
Registry update: 1 Aug 2024

Ordered by registry start date. Freshness and sponsorship never change the order.